Page 138 - Read Online

28. Floden AM, Li S, Combs CK. Beta‑amyloid‑stimulated microglia 38. Chang Y, Lee JJ, Hsieh CY, Hsiao G, Chou DS, Sheu JR. Inhibitory
induce neuron death via synergistic stimulation of tumor necrosis effects of ketamine on lipopolysaccharide‑induced microglial
factor alpha and NMDA receptors. J Neurosci 2005;25:2566‑75. activation. Mediators Inflamm 2009;2009:705379.
29. Schnieder TP, Trencevska I, Rosoklija G, Stankov A, Mann JJ, 39. Liu D, Wang Z, Liu S, Wang F, Zhao S, Hao A. Anti‑inflammatory
Smiley J, Dwork AJ. Microglia of prefrontal white matter in suicide. effects of fluoxetine in lipopolysaccharide (LPS)‑stimulated
J Neuropathol Exp Neurol 2014;73:880‑90. microglial cells. Neuropharmacology 2011;61:592‑9.
30. Myint AM, Kim YK. Cytokine‑serotonin interaction through IDO: 40. Obuchowicz E, Kowalski J, Labuzek K, Krysiak R, Pendzich J,
a neurodegeneration hypothesis of depression. Med Hypotheses Herman ZS. Amitriptyline and nortriptyline inhibit interleukin‑1
2003;61:519‑25. release by rat mixed glial and microglial cell cultures. Int J
31. Hu B, Hissong BD, Carlin JM. Interleukin‑1 enhances indoleamine Neuropsychopharmacol 2006;9:27‑35.
2, 3‑dioxygenase activity by increasing specific mRNA expression 41. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC. Clomipramine
in human mononuclear phagocytes. J Interferon Cytokine Res treatment reversed the glial pathology in a chronic unpredictable
1995;15:617‑24. stress‑induced rat model of depression. Eur Neuropsychopharmacol
32. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, 2009;19:796‑805.
Moroni F. Presynaptic kynurenate‑sensitive receptors inhibit 42. Rajkowska G, Miguel‑Hidalgo JJ. Gliogenesis and glial pathology
glutamate release. Eur J Neurosci 2001;13:2141‑7. in depression. CNS Neurol Disord Drug Targets 2007;6:219‑33.
33. Pocivavsek A, Wu HQ, Potter MC, Elmer GI, Pellicciari R, 43. Rajkowska G, O’Dwyer G, Teleki Z, Stockmeier CA,
Schwarcz R. Fluctuations in endogenous kynurenic acid control Miguel‑Hidalgo JJ. GABAergic neurons immunoreactive for
hippocampal glutamate and memory. Neuropsychopharmacology calcium binding proteins are reduced in the prefrontal cortex in
2011;36:2357‑67. major depression. Neuropsychopharmacology 2007;32:471‑82.
34. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. 44. Rajkowska G, Miguel‑Hidalgo JJ, Dubey P, Stockmeier CA,
Pharmacol Rev 1993;45:309‑79. Krishnan KR. Prominent reduction in pyramidal neurons density in
35. Moroni F. Tryptophan metabolism and brain function: focus the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry
on kynurenine and other indole metabolites. Eur J Pharmacol 2005;58:297‑306.
1999;375:87‑100.
36. Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS
J 2012;279:1356‑65. Cite this article as: Serafini G, Rihmer Z, Amore M. The role of glutamate
37. Corona AW, Huang Y, O’Connor JC, Dantzer R, Kelley KW, excitotoxicity and neuroinflammation in depression and suicidal behavior:
focus on microglia cells. Neuroimmunol Neuroinflammation 2015;2(3):127-30.
Popovich PG, Godbout JP. Fractalkine receptor (CX3CR1) Source of Support: Nil. Conflict of Interest: No.
deficiency sensitizes mice to the behavioral changes induced by
lipopolysaccharide. J Neuroinflammation 2010;7:93. Received: 25-09-2014; Accepted: 18-01-2015

130 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 PB